Plasma metabolites associated with arterial stiffness in patients with type 2 diabetes
暂无分享,去创建一个
E. Fukusaki | T. Bamba | I. Shimomura | T. Matsuoka | H. Tsugawa | M. Furuno | M. Takahara | N. Katakami | Naohiro Taya | Kazuo Omori | Shoya Arakawa
[1] A. Goto,et al. Japanese Clinical Practice Guideline for Diabetes 2019 , 2020, Journal of diabetes investigation.
[2] E. Fukusaki,et al. Identification of Plasma Inositol and Indoxyl Sulfate as Novel Biomarker Candidates for Atherosclerosis in Patients with Type 2 Diabetes. -Findings from Metabolome Analysis Using GC/MS- , 2020, Journal of atherosclerosis and thrombosis.
[3] T. Berendschot,et al. The oral glucose tolerance test-derived incremental glucose peak is associated with greater arterial stiffness and maladaptive arterial remodeling: The Maastricht Study , 2019, Cardiovascular Diabetology.
[4] L. Liang,et al. Lysine pathway metabolites and the risk of type 2 diabetes and cardiovascular disease in the PREDIMED study: results from two case-cohort studies , 2019, Cardiovascular Diabetology.
[5] W. Rathmann,et al. Glucose and insulin levels are associated with arterial stiffness and concentric remodeling of the heart , 2019, Cardiovascular diabetology.
[6] Xiaoying Gu,et al. Novel Metabolites Are Associated With Augmentation Index and Pulse Wave Velocity: Findings From the Bogalusa Heart Study , 2019, American journal of hypertension.
[7] T. Bamba,et al. Identification of novel serum markers for the progression of coronary atherosclerosis in WHHLMI rabbits, an animal model of familial hypercholesterolemia. , 2019, Atherosclerosis.
[8] A. Goto,et al. Japanese Clinical Practice Guideline for Diabetes 2016 , 2018, Journal of diabetes investigation.
[9] Min Kyung Kim,et al. Association between triglyceride glucose index and arterial stiffness in Korean adults , 2018, Cardiovascular Diabetology.
[10] N. Katakami. Mechanism of Development of Atherosclerosis and Cardiovascular Disease in Diabetes Mellitus , 2018, Journal of atherosclerosis and thrombosis.
[11] S. Piro,et al. HbA1c Identifies Subjects With Prediabetes and Subclinical Left Ventricular Diastolic Dysfunction , 2017, The Journal of clinical endocrinology and metabolism.
[12] T. Hoffmann,et al. N-terminal pyroglutamate formation in CX3CL1 is essential for its full biologic activity , 2017, Bioscience reports.
[13] S. Yamashita,et al. Homogeneous Assays for LDL-C and HDL-C are Reliable in Both the Postprandial and Fasting State , 2017, Journal of atherosclerosis and thrombosis.
[14] G. Regolisti,et al. Intestinal Microbiota in Type 2 Diabetes and Chronic Kidney Disease , 2017, Current Diabetes Reports.
[15] D. Tarng,et al. Indoxyl Sulfate: A Novel Cardiovascular Risk Factor in Chronic Kidney Disease , 2017, Journal of the American Heart Association.
[16] W. Currenti,et al. Low advanced glycation end product diet improves the lipid and inflammatory profiles of prediabetic subjects. , 2016, Journal of clinical lipidology.
[17] Z. Massy,et al. Role of the Gut Microbiome in Uremia: A Potential Therapeutic Target. , 2016, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[18] Minjoo Kim,et al. Associations between metabolomic‐identified changes of biomarkers and arterial stiffness in subjects progressing to impaired fasting glucose , 2015, Clinical endocrinology.
[19] Alex F. Chen,et al. Dietary Intake of Sugar Substitutes Aggravates Cerebral Ischemic Injury and Impairs Endothelial Progenitor Cells in Mice , 2015, Stroke.
[20] G. Regolisti,et al. Alterations of intestinal barrier and microbiota in chronic kidney disease. , 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[21] Masanori Arita,et al. MS-DIAL: Data Independent MS/MS Deconvolution for Comprehensive Metabolome Analysis , 2015, Nature Methods.
[22] Minjoo Kim,et al. Association between Arterial Stiffness and Serum L-Octanoylcarnitine and Lactosylceramide in Overweight Middle-Aged Subjects: 3-Year Follow-Up Study , 2015, PloS one.
[23] Ji-Hyun Kim,et al. Brachial-ankle pulse wave velocity for the prediction of the presence and severity of coronary artery disease , 2014, Clinical and experimental hypertension.
[24] I. Shimomura,et al. Clinical utility of brachial-ankle pulse wave velocity in the prediction of cardiovascular events in diabetic patients , 2014, Cardiovascular Diabetology.
[25] R. Vanholder,et al. The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: a systematic review. , 2014, Journal of the American Society of Nephrology : JASN.
[26] Masanori Arita,et al. MRMPROBS suite for metabolomics using large-scale MRM assays , 2014, Bioinform..
[27] Yuko Sakurai,et al. Gut Dysbiosis and Detection of “Live Gut Bacteria” in Blood of Japanese Patients With Type 2 Diabetes , 2014, Diabetes Care.
[28] S. Shibata,et al. Efficacy of combined use of three non-invasive atherosclerosis tests to predict vascular events in the elderly; carotid intima-media thickness, flow-mediated dilation of brachial artery and pulse wave velocity. , 2013, Atherosclerosis.
[29] C. Lau,et al. Association of subclinical myocardial injury with arterial stiffness in patients with type 2 diabetes mellitus , 2013, Cardiovascular Diabetology.
[30] M. Hayashi,et al. Indoxyl sulfate, a uremic toxin, and carotid intima-media thickness in patients with coronary artery disease. , 2013, International journal of cardiology.
[31] Hsuan-Liang Liu,et al. Indoxyl sulfate predicts cardiovascular disease and renal function deterioration in advanced chronic kidney disease. , 2012, Archives of medical research.
[32] Y. Paik,et al. The association of specific metabolites of lipid metabolism with markers of oxidative stress, inflammation and arterial stiffness in men with newly diagnosed type 2 diabetes , 2012, Clinical endocrinology.
[33] H. Ueshima,et al. Brachial–ankle pulse wave velocity predicts all-cause mortality in the general population: findings from the Takashima study, Japan , 2010, Hypertension Research.
[34] T. Sugiura,et al. Association between brachial–ankle pulse wave velocity and 3-year mortality in community-dwelling older adults , 2010, Hypertension Research.
[35] A. Bast,et al. Erythritol is a sweet antioxidant. , 2010, Nutrition.
[36] Yasuhiko Tomino,et al. Revised equations for estimated GFR from serum creatinine in Japan. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[37] Stéphane Laurent,et al. Recent advances in arterial stiffness and wave reflection in human hypertension. , 2007, Hypertension.
[38] H. Struijker‐Boudier,et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. , 2006, European heart journal.
[39] Y. Ouchi,et al. Serum lipid survey and its recent trend in the general Japanese population in 2000. , 2005, Journal of atherosclerosis and thrombosis.
[40] S. Haffner. Insulin resistance, inflammation, and the prediabetic state. , 2003, The American journal of cardiology.
[41] A. Yamashina,et al. Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. , 2002, Hypertension research : official journal of the Japanese Society of Hypertension.
[42] S. Morikawa,et al. Increased arterial wall stiffness limits flow volume in the lower extremities in type 2 diabetic patients. , 2001, Diabetes care.
[43] P. Ducimetiere,et al. Aortic Stiffness Is an Independent Predictor of All-Cause and Cardiovascular Mortality in Hypertensive Patients , 2001, Hypertension.
[44] Lianwei Jiang,et al. Mannitol at clinical concentrations activates multiple signaling pathways and induces apoptosis in endothelial cells. , 1998, Stroke.
[45] R T Borchardt,et al. Inhibitory effect of sugars and polyols on the metal-catalyzed oxidation of human relaxin. , 1996, Journal of pharmaceutical sciences.
[46] Hilde van der Togt,et al. Publisher's Note , 2003, J. Netw. Comput. Appl..